Related Experiment Videos
Pulmonary involvement in angio-immunoblastic lymphadenopathy.
Postgraduate Medical Journal
|November 1, 1983
Summary
Two patients with angio-immunoblastic lymphadenopathy experienced respiratory and systemic symptoms. High-dose corticosteroid therapy effectively relieved symptoms and improved lung imaging, indicating a positive treatment response.
Area of Science:
- Immunology
- Pulmonology
- Oncology
Background:
- Angio-immunoblastic lymphadenopathy (AIL) is an aggressive non-Hodgkin lymphoma.
- Pulmonary involvement in AIL can lead to severe respiratory compromise.
Observation:
- Two patients presented with dyspnea and systemic symptoms.
- Extensive pulmonary infiltrates were observed on radiographic imaging.
Findings:
- High-dose corticosteroid therapy was administered to both patients.
- Significant relief of symptoms and resolution of radiographic pulmonary shadowing were achieved.
Implications:
- Corticosteroids may be an effective treatment for pulmonary manifestations of AIL.
- Early diagnosis and intervention can improve patient outcomes in AIL with lung involvement.